Bukwang Pharm Co Ltd
KRX:003000
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bukwang Pharm Co Ltd
KRX:003000
|
KR |
|
M
|
M&A Research Institute Inc
TSE:9552
|
JP |
|
Tencent Music Entertainment Group
NYSE:TME
|
CN |
|
Cherry Hill Mortgage Investment Corp
NYSE:CHMI
|
US |
|
WELL Health Technologies Corp
TSX:WELL
|
CA |
|
Gold Resource Corp
LSE:0IYS
|
US |
|
Imperial Metals Corp
TSX:III
|
CA |
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
AU |
Dividends
Dividend Yield
Bukwang Pharm Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Bukwang Pharm Co Ltd
Bukwang Pharm Co Ltd have
decreased
by 69%.
Payout Ratio
Bukwang Pharm Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Bukwang Pharm Co Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Bukwang Pharm Co Ltd
| Average Annual Return | -32.73% |
| Standard Deviation of Annual Returns | 7.52% |
| Max Drawdown | -86% |
| Market Capitalization | 947.2B KRW |
| Shares Outstanding | 98 660 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Bukwang Pharm Co Ltd's latest stock split occurred on Dec 29, 2020
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Bukwang Pharm Co Ltd traded at 29000.0009 per share. Afterward, the share price was about 26796.2264.
The adjusted shares began trading on Dec 29, 2020. This was Bukwang Pharm Co Ltd's 18th stock split, following the previous one in Dec 27, 2019.
